Orris

Toxic amblyopia

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Here is a comprehensive overview of toxic amblyopia (also called toxic/nutritional optic neuropathy or "tobacco-alcohol amblyopia"):

Toxic Amblyopia

Definition & Terminology

"Toxic amblyopia" is an older term for toxic/nutritional optic neuropathy — a bilateral optic nerve disorder caused by nutritional deficiencies and/or toxic exposures. The classic form, once called "tobacco-alcohol amblyopia," is now understood to be primarily nutritional rather than truly toxic in most cases. Both mechanisms (nutritional deficiency and direct toxicity) can affect the optic nerves, and clinically they are indistinguishable.

Pathophysiology

The central mechanism is deficient mitochondrial function in the papillomacular bundle of the optic nerve — the same mechanism seen in hereditary optic neuropathies (e.g., Leber hereditary optic neuropathy). This preferentially damages the papillomacular fibers, causing central or cecocentral scotomas. At the structural level, there is loss of myelin and axon cylinders restricted to the papillomacular fiber region, with demyelination sometimes also affecting the posterior columns of the spinal cord.

Etiology

Nutritional:
  • Deficiency of B-complex vitamins — particularly B12 (cyanocobalamin), B1 (thiamine), B2 (riboflavin), B3 (niacin), and B6 (pyridoxine)
  • Folate deficiency
  • Copper, protein deficiency
  • Pernicious anaemia (impaired B12 absorption)
  • Strict vegan diet
  • Severe malnutrition (e.g., prisoners of war; epidemic forms in Cuba, Jamaica, Tanzania)
Toxic/Drug-Related:
  • Tobacco/alcohol — likely act primarily through nutritional depletion, not direct toxicity; the cyanide-from-tobacco hypothesis is not well supported
  • Medications: ethambutol, chloramphenicol, linezolid, isoniazid, amiodarone, digitalis, streptomycin, disulfiram, chlorpropamide, ethchlorvynol
  • Methanol — causes acute optic neuropathy
  • Heavy metals — lead, thallium
  • Ibuprofen and niacin (rare, reversible)

Symptoms

  • Painless, gradually progressive (over days to weeks), bilateral visual loss
  • Blurring for both near and far objects
  • Disturbed colour vision (often disproportionately reduced relative to acuity)

Signs

FeatureDescription
Visual acuity20/50 to 20/200
Visual fieldsBilateral cecocentral or central scotomas (larger for colored than white targets)
Color visionReduced; red desaturation common
Optic discNormal initially; later temporal disc pallor and optic atrophy
PupilOften normal; may be sluggish in severe cases

Investigations (Workup)

  • Full history: diet, alcohol/tobacco, medications, occupational exposure
  • Complete eye exam: pupils (RAPD), color vision (Ishihara), optic nerve
  • Formal visual fields (Humphrey/Goldmann)
  • OCT: peripapillary RNFL thickening; excludes macular pathology
  • VEP: reduced P100 amplitude
  • Bloods: serum B12, B1, folate (serum and red cell), CBC with film (macrocytic anaemia), serum protein; methylmalonate and homocysteine if B12 borderline
  • Heavy metal screen (lead, thallium) if indicated
  • Consider LHON (mitochondrial DNA testing) to exclude Leber hereditary optic atrophy

Treatment

  1. Remove the causative agent — stop offending drug, alcohol, tobacco
  2. Nutritional supplementation:
    • Thiamine 100 mg orally twice daily
    • Folate 1.0 mg orally daily
    • Multivitamin daily
    • B12 1,000 mcg IM monthly (for pernicious anaemia)
  3. Dietary improvement
Prognosis: Good if treated early — improvement occurs in almost all cases. Colour perception recovers more slowly than acuity. In chronic/advanced cases, permanent visual deficit is likely; complete loss of peripheral vision is rare.

Key Differentials

  • Leber hereditary optic neuropathy (LHON) — can mimic tobacco-alcohol amblyopia; exclude with mitochondrial DNA testing
  • Dominant juvenile optic atrophy
  • Compressive optic neuropathy
  • Multiple sclerosis
Sources: The Wills Eye Manual, p. 721–722; Adams and Victor's Principles of Neurology (12th ed.), p. 1181; Kanski's Clinical Ophthalmology (10th ed.), p. 792; Goodman & Gilman's Pharmacological Basis of Therapeutics
This is a shared conversation. Sign in to Orris to start your own chat.